Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Vacuolar proton-translocating ATPase (V-ATPase) is a membrane-bound, multi-subunit enzyme that uses the energy of ATP hydrolysis to pump protons across membranes. V-ATPase activity is critical for pH homeostasis and organelle acidification as well as for generation of the membrane potential that drives secondary transporters and cellular metabolism. V-ATPase is highly conserved across species and is best characterized in the model fungus Saccharomyces cerevisiae. However, recent studies in mammals have identified significant alterations from fungi, particularly in the isoform composition of the 14 subunits and in the regulation of complex disassembly. These differences could be exploited for selectivity between fungi and humans and highlight the potential for V-ATPase as an anti-fungal drug target. Candida albicans is a major human fungal pathogen and causes fatality in 35% of systemic infections, even with anti-fungal treatment. The pathogenicity of C. albicans correlates with environmental, vacuolar, and cytoplasmic pH regulation, and V-ATPase appears to play a fundamental role in each of these processes. Genetic loss of V-ATPase in pathogenic fungi leads to defective virulence, and a comprehensive picture of the mechanisms involved is emerging. Recent studies have explored the practical utility of V-ATPase as an anti-fungal drug target in C. albicans, including pharmacological inhibition, azole therapy, and targeting of downstream pathways. This overview will discuss these studies as well as hypothetical ways to target V-ATPase and novel high-throughput methods for use in future drug discovery screens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179 · cited 2×
“Additionally, both activation and secretion of the proteinase and lipase virulence factors and activity of the enzymes themselves require optimal vacuolar pH (Naglik et al., 2003).”
BackgroundGrowth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110 · cited 4×
“The non-pathogenic yeast form of the fungus grows preferentially under acidic environmental conditions while increasing extracellular pH triggers hyphal growth and increased virulence (Sudbery, 2011).”
BackgroundInfluentialHorn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956 · cited 1×
“Critically, patient mortality rates can reach 35% even with anti-fungal treatment (Horn et al., 2009).”
BackgroundPhagocytosis and Intracellular Fate of Aspergillus fumigatus Conidia in Alveolar Macrophages
Ibrahim-Granet, O., Philippe, B., Boleti, H., Boisvieux-Ulrich, E., Grenet, D., Stern, M., & Latgé, J. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.2.891-903.2003 · Cited by 277
Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast
Martínez-Muñoz, G. A., & Kane, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710470200 · Cited by 257
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
Zhang, Y.-Q., Gamarra, S., Garcia-Effron, G., Park, S., Perlin, D. S., & Rao, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000939 · Cited by 206
How human pathogenic fungi sense and adapt to pH: the link to virulence
Davis, D. A. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.05.006 · Cited by 177 · cited 1×
“C. albicans has developed mechanisms that allow it to rapidly respond to environmental pH changes, and mutants lacking the ability to sense extracellular pH display reduced virulence (Davis, 2009).”
BackgroundAn endocytic mechanism for haemoglobin‐iron acquisition in Candida albicans
Weissman, Z., Shemer, R., Conibear, E., & Kornitzer, D. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06277.x · Cited by 127
Jia, N., Arthington-Skaggs, B., Lee, W., Pierson, C. A., Lees, N. D., Eckstein, J., Barbuch, R., & Bard, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.947-957.2002 · Cited by 61
Cited by
Proton transport and pH control in fungi
Kane, P. M. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_3 · Cited by 131
Feng, J., Weitner, M., Shi, W., Zhang, S., Sullivan, D., & Zhang, Y. (2015) · Antibiotics · doi:10.3390/antibiotics4030397 · Cited by 43
“albicans, thonzonium bromide was also shown to inhibit ATPases in isolated vacuoles and cause general cellular toxicity [33,34].”
BackgroundAttenuation of Candida albicans virulence with focus on disruption of its vacuole functions
Olsen, I. (2014) · Journal of Oral Microbiology · doi:10.3402/jom.v6.23898 · Cited by 22
“Anti-V-ATPase drugs Anti-V-ATPase drugs may be effective in the treatment of candidosis (29).”
BackgroundInfluential
Metadata
- Authors
- Hayek, S. R., Lee, S. A., & Parra, K. J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 4-4
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2107256297
- Cited by
- 35
- References
- 9
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy. https://app.cochat.ai/papers/10.3389/fphar.2014.00004
- The paper
- Hayek, S. R., Lee, S. A., & Parra, K. J. (2014). Advances in targeting the vacuolar proton-translocating ATPase (V-ATPase) for anti-fungal therapy. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2014.00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.